Search hospitals > Missouri > Rolla

Delbert Day Cancer Institute at PCRMC

Claim this profile
Rolla, Missouri 65401
Global Leader in Cancer
Global Leader in Adenocarcinoma
Conducts research for Breast Cancer
Conducts research for Lung Cancer
Conducts research for Tumors
264 reported clinical trials
1 medical researcher
Photo of Delbert Day Cancer Institute at PCRMC in RollaPhoto of Delbert Day Cancer Institute at PCRMC in RollaPhoto of Delbert Day Cancer Institute at PCRMC in Rolla

Summary

Delbert Day Cancer Institute at PCRMC is a medical facility located in Rolla, Missouri. This center is recognized for care of Cancer, Adenocarcinoma, Breast Cancer, Lung Cancer, Tumors and other specialties. Delbert Day Cancer Institute at PCRMC is involved with conducting 264 clinical trials across 433 conditions. There are 1 research doctors associated with this hospital, such as Jay W Carlson.

Area of expertise

1Cancer
Global Leader
Delbert Day Cancer Institute at PCRMC has run 117 trials for Cancer. Some of their research focus areas include:
Stage IV
Stage III
Stage II
2Adenocarcinoma
Global Leader
Delbert Day Cancer Institute at PCRMC has run 40 trials for Adenocarcinoma. Some of their research focus areas include:
Stage IV
Stage III
Stage II

Top PIs

Clinical Trials running at Delbert Day Cancer Institute at PCRMC

Breast Cancer
Cancer
Bladder Cancer
Non-Small Cell Lung Cancer
Lung Cancer
Prostate Cancer
Squamous Cell Carcinoma
Bladder Carcinoma
Gastric Cancer
Renal Cell Carcinoma
Image of trial facility.

Chemotherapy + Hormone Therapy

for Breast Cancer

This Phase III Trial will determine whether adjuvant chemotherapy (ACT) added to ovarian function suppression (OFS) plus endocrine therapy (ET) is superior to OFS plus ET in improving invasive breast cancer-free survival (IBCFS) among premenopausal, early- stage breast cancer (EBC) patients with estrogen receptor (ER)-positive, HER2-negative tumors and 21-gene recurrence score (RS) between 16-25 (for pN0 patients) and 0-25 (for pN1 patients).
Recruiting2 awards Phase 319 criteria
Image of trial facility.

Shorter Chemo-Immunotherapy Without Anthracyclines

for Breast Cancer

This phase III trial compares the effects of shorter chemotherapy (chemo)-immunotherapy without anthracyclines to usual chemo-immunotherapy for the treatment of early-stage triple negative breast cancer. Paclitaxel is in a class of medications called anti-microtubule agents. It stops cancer cells from growing and dividing and may kill them. Carboplatin is in a class of medications known as platinum-containing compounds. It works in a way similar to the anticancer drug cisplatin, but may be better tolerated than cisplatin. Carboplatin works by killing, stopping or slowing the growth of cancer cells. Cyclophosphamide is in a class of medications called alkylating agents. It works by damaging the cell's deoxyribonucleic acid (DNA) and may kill cancer cells. It may also lower the body's immune response. Docetaxel is in a class of medications called taxanes. It stops cancer cells from growing and dividing and may kill them. Doxorubicin is an anthracycline chemotherapy drug that damages DNA and may kill cancer cells. Pembrolizumab may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth. Shorter treatment without anthracycline chemotherapy may work the same as the usual anthracycline chemotherapy treatment for early-stage triple negative breast cancer.
Recruiting2 awards Phase 347 criteria
Image of trial facility.

Support Program

for Breast Cancer

This study is evaluating whether a support program may help breast cancer patients take their medication correctly.
Recruiting2 awards Phase 34 criteria

Similar Hospitals nearby

Frequently asked questions

What kind of research happens at Delbert Day Cancer Institute at PCRMC?
Delbert Day Cancer Institute at PCRMC is a medical facility located in Rolla, Missouri. This center is recognized for care of Cancer, Adenocarcinoma, Breast Cancer, Lung Cancer, Tumors and other specialties. Delbert Day Cancer Institute at PCRMC is involved with conducting 264 clinical trials across 433 conditions. There are 1 research doctors associated with this hospital, such as Jay W Carlson.